Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,738018,Anxrr4,Anxiety related response QTL 4,5.1,,exploratory behavior trait (VT:0010471),percentage of entries into a discrete space in an experimental apparatus (CMO:0000961),5,136354114,173707219,Rat,n/a,region,qtl 1000,631562,Apr2,Acute phase response QTL 2,3.7,,blood murinoglobulin 1 amount (VT:0010597),plasma murinoglobulin 1 level (CMO:0001931),5,142307322,173707219,Rat,n/a,region,qtl 1000,634349,Bp139,Blood pressure QTL 139,,0.001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,134197905,173707219,Rat,n/a,region,qtl 1000,724525,Bp147,Blood pressure QTL 147,4.3,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,132551937,173707219,Rat,n/a,region,qtl 1000,1331721,Bp210,Blood pressure QTL 210,3.413,,arterial blood pressure trait (VT:2000000),blood pressure time series experimental set point of the baroreceptor response (CMO:0002593),5,149029982,173687766,Rat,n/a,region,qtl 1000,1598819,Bp292,Blood pressure QTL 292,4.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),5,133943857,173707219,Rat,n/a,region,qtl 1000,8694169,Bw148,Body weight QTL 148,5,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),5,134712342,173707219,Rat,n/a,region,qtl 1000,1598861,Cm64,Cardiac mass QTL 64,2.9,,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),5,133943857,173707219,Rat,n/a,region,qtl 1000,1641920,Colcs1,Colorectal carcinoma susceptibility QTL 1,2.99,0.0055,intestine integrity trait (VT:0010554),benign colorectal tumor surface area measurement (CMO:0001799),5,128687766,173687766,Rat,n/a,region,qtl 1000,631272,Lanf1,Left ventricular atrial natriuretic factor QTL 1,12,,heart left ventricle natriuretic peptide A amount (VT:0010596),heart left ventricle natriuretic peptide A level (CMO:0002165),5,157319671,173707219,Rat,n/a,region,qtl 1000,7794791,Mcs33,Mammary carcinoma susceptibility QTL 33,1.93,,mammary gland integrity trait (VT:0010552),mammary tumor incidence/prevalence measurement (CMO:0000946),5,136640731,173707219,Rat,n/a,region,qtl 1000,1549904,Neuinf1,Neuroinflammation QTL 1,3,0,nervous system integrity trait (VT:0010566),blood T lymphocyte count (CMO:0000110),5,161084664,173707219,Rat,n/a,region,qtl 1000,8552908,Pigfal4,Plasma insulin-like growth factor 1 level QTL 4,6.6,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),5,134712342,173707219,Rat,n/a,region,qtl 1000,1302790,Scl20,Serum cholesterol level QTL 20,6.4,0.0001,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),5,84963058,173504662,Rat,n/a,region,qtl 1000,10053720,Scort26,Serum corticosterone level QTL 26,2.06,0.0147,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),5,131077716,173707219,Rat,n/a,region,qtl 1000,61444,Strs2,Sensitivity to stroke QTL 2,4.7,,cerebrum integrity trait (VT:0010549),post-insult time to onset of cerebrovascular lesion (CMO:0002343),5,142309061,173707219,Rat,n/a,region,qtl